No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CDLX240517P9000
- 0.10
- -0.05-33.33%
15min DelayTrading May 15 12:36 ET
0.20High0.10Low
0.20Open0.15Pre Close6 Volume146 Open Interest9.00Strike Price110.00Turnover97.25%IV-6.81%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.10Time Value100Contract SizeAmericanOptions Type-0.2639Delta0.4364Gamma95.50Leverage Ratio-0.0537Theta-0.0002Rho-25.20Eff Leverage0.0025Vega
Intraday
- 5D
- 1D
News
(SEC Amendment) Cardlytics(CDLX.US) 10% Shareholder Buys US$2.88 Million in Common Stock
$Cardlytics(CDLX.US)$ 10% Shareholder SOSIN CLIFFORD purchased 328.75K shares of common stock on May 9, 10, 13, 2024 at an average price of $8.7481 for a total value of $2.88 million.Source: Announcem
Cardlytics(CDLX.US) 10% Shareholder Buys US$2.88 Million in Common Stock
$Cardlytics(CDLX.US)$ 10% Shareholder SOSIN CLIFFORD purchased 328.75K shares of common stock on May 9, 10, 13, 2024 at an average price of $8.7481 for a total value of $2.88 million.Source: Announcem
Cardlytics Inc (CDLX) Reports Q1 2024 Earnings: A Detailed Analysis
Why Cardlytics Stock Collapsed on Thursday
Shares of advertising technology company Cardlytics (CDLX -36.51%) imploded Thursday morning, falling 32% through 10:15 a.m. ET after reporting what -- in all honesty -- didn't look like much of a miss last night.
Express News | Craig-Hallum Maintains Buy on Cardlytics, Lowers Price Target to $12
Cardlytics Shares Plummet After Swing to 1Q Loss, Revenue Miss
By Dean Seal Shares of Cardlytics sank after the company swung to a first-quarter loss and posted revenue that didn't meet analyst expectations. The stock was down 41% at $8.67 in recent trading. Sh
Comments
$Cardlytics(CDLX.US$ 15 tonight!!
Cardlytics' unique position with access to large datasets could be a boon as AI adoption progresses. Its acquisition of Dosh is expected to strengthen its position in the underbanked category. CDLX stock is deemed a 'Strong Buy'.
4
1
$Cardlytics(CDLX.US$ Clifford Sosin, 10% Owner, around March 15, 2024, executed a purchase for 661,715 shares in Cardlytics (CDLX) for $8,963,859. Following the Form 4 filing with the SEC, Sosin has control over a total of 6,023,676 shares of the company, with 6,023,676 shares controlled indirectly.
Cardlytics Inc. Surpasses Earnings Estimates despite Sales Shortfall: An In-depth Analysis.
Cardlytics Inc. (NASDAQ: $CDLX), a leading advertising platform in banks' digital channels, recently announced its quarterly earnings, outperforming analysts' consensus estimate. However, the company fell short of projected sales figures. This article provides an in-depth analysis of Cardlytics' financial performance, shedding light on what these res...
Cardlytics Inc. (NASDAQ: $CDLX), a leading advertising platform in banks' digital channels, recently announced its quarterly earnings, outperforming analysts' consensus estimate. However, the company fell short of projected sales figures. This article provides an in-depth analysis of Cardlytics' financial performance, shedding light on what these res...
3
Read more